breast cancer
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients who meet all of the following criteria; 1. Aged 20 years and older 2. Received mastectomy, pathologically confirmed breast cancer, and needed to receive postmastectomy radiotherapy 3. Performance status (ECOG) 0-2 4. Written informed consent
Exclusion criteria
Exclusion criteria: 1. Patients have other concomitant active malignancy except carcinoma in situ. 2. Patients have uncontrolled diabetes. 3. Patients have active interstitial pneumonitis or lung fibrosis or advanced pulmonary emphysema. 4. Patients have active collagen disease. 5. Patients have heart failure, myocardial infarction or angina pectoris within 6 months. 6. Patients have pregnancy or nursing. 7. Patients have psychiatric disorders that may comprise the patient's ability to receive radiotherapy. 8. Patients have breast reconstruction before radiotherapy 9. Patients have prior overlapping radiation. 10. Patients who need to receive boost irradiation for positive surgical margin. 11.Patients who is considered ineligible for enrolling the study by a principal investigator or sub-investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Skin toxicity from start of radiotherapy to 12 weeks after completion of radiotherapy | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Chest wall recurrences during observation 2. Skin dose using dosimeters within 5 times of beginning radiation | — |
Countries
Japan
Contacts
Juntendo University Department of Radiation Oncology